, International Statistical Classification of Diseases and Related Health Problems 10e révision Version, pp.43-44, 2016.
Guide pour les personnes qui ont vécu un événement traumatique ,
,
, American Psychiatric Association, éditeurs. Diagnostic and statistical manual of mental disorders: DSM-5, 2013.
Handbook of PTSD, Second Edition: Science and Practice, p.p, 2014. ,
Trauma And Its Wake ,
, History of PTSD in Veterans: Civil War to DSM-5 -PTSD: National Center for PTSD
,
Les drogues et la guerre: de l'Antiquite a nos jours, vol.162, 2017. ,
No More Heroes: Madness and Psychiatry In War. Farrar, Straus and Giroux, vol.58, 1988. ,
Encyclopedia of Trauma: An Interdisciplinary Guide, vol.624, 2012. ,
Research on PTSD and other post-traumatic reactions: European literature ,
, American Psychological Association, 1991.
The neurological manifestations of trauma: lessons from World War I, Eur Arch Psychiatry Clin Neurosci. 1 avr, vol.262, issue.3, pp.253-64, 2012. ,
Contemporary Psychiatry, 2013. ,
Traumatic Stress: The Effects of Overwhelming Experience on Mind, Body, and Society. 1 edition, vol.596, 2006. ,
,
,
Traumatic Stress: The Effects of Overwhelming Experience on Mind, vol.709, 1996. ,
, Rev Neurol (Paris), vol.142, issue.5, pp.489-99, 1986.
, Rev Neurol (Paris), vol.142, issue.5, pp.489-99, 1987.
,
, Encephale. déc, vol.34, issue.6, pp.577-83, 2008.
Posttraumatic stress disorder in the National Comorbidity Survey, Arch Gen Psychiatry. déc, vol.52, issue.12, pp.1048-60, 1995. ,
Review of somatic symptoms in post-traumatic stress disorder, Int Rev Psychiatry. févr, vol.25, issue.1, pp.86-99, 2013. ,
Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey, Journal of Traumatic Stress, vol.21, issue.5, pp.455-62, 2008. ,
Exposure to Traumatic Events and Posttraumatic Stress Disorder in France: Results From the WMH Survey, J Trauma Stress. août, vol.28, issue.4, pp.275-82, 2015. ,
Differences in prevalence rates of PTSD in various European countries explained by war exposure, other trauma and cultural value orientation, BMC Research Notes. 28 juin, vol.7, issue.1, p.407, 2014. ,
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication, Arch Gen Psychiatry. juin, vol.62, issue.6, pp.593-602, 2005. ,
, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication, vol.62, pp.617-644, 2005.
,
, Les psychothérapies comportementales et cognitives -5th Edition
Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews, Disponible sur, p.15, 2013. ,
, , 2019.
,
Introduction aux thérapies comportementales (Behavior therapies) . Historique. Bases théoriques. Pratique, Revue Philosophique de Louvain, vol.79, issue.44, pp.598-598, 1981. ,
, Group & Organization Studies. 1 sept, vol.2, issue.3, pp.384-389, 1977.
Pleine conscience et acceptation : Les thérapies de la troisième Vague. Première Édition, vol.352, 2015. ,
, Réflexes conditionnels et inhibitions. Gonthier, 1963.
The Emotional Brain: The Mysterious Underpinnings of Emotional Life, vol.384, 1998. ,
Analyse expérimentale du comportement. Un essai théorique, Contingencies of reinforcement: A theorical analysis, 1971. ,
, xvii, 682. (Fears, phobias, and rituals: Panic, anxiety, and their disorders), 1987.
The Practice of Behavior Therapy ,
Helplessness : on depression, 1975. ,
Cognitive Therapy of Depression, vol.442, 1979. ,
The integrative power of cognitive therapy, The integrative power of cognitive therapy), 1997. ,
Les thérapies cognitives: Comment agir sur nos pensées et nos émotions ? Retz, 2011. ,
Psychothérapies cognitives des troubles de la personnalité. 2e édition revue et augmentée, vol.320, 2006. ,
Thérapie cognitive et émotions: La troisième vague. 2e édition, vol.224, 2014. ,
Acceptance and Commitment Therapy, Second Edition: The Process and Practice of Mindful Change ,
La thérapie des schémas : Approche cognitive des troubles de la personnalité, vol.564, 2015. ,
Positive psychology progress: empirical validation of interventions, Am Psychol. août, vol.60, issue.5, pp.410-431, 2005. ,
, Les effets de la mindfulness et des interventions psychologiques basées sur la pleine conscience -EM|consulte
A multi-method examination of the effects of mindfulness on stress attribution, coping, and emotional well-being, Journal of Research in Personality. 1 juin, vol.43, pp.374-85, 2009. ,
Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis, 1998. ,
Meta-analysis of the efficacy of treatments for posttraumatic stress disorder, J Clin Psychiatry. juin, vol.74, issue.6, pp.541-550, 2013. ,
EMDR : L'histoire, la méthode et les techniques pour se libérer de ses traumatismes et dépasser ses blocages. 1 re éd ,
Eye Movement Desensitization and Reprocessing (EMDR): Basic Principles, Protocols, and Procedures, 1995. ,
Eye Movement Desensitization and Reprocessing (EMDR) Therapy, Third Edition: Basic Principles, Protocols, and Procedures, vol.593, 2017. ,
Emdr As an Integrative Psychotherapy Approach: Experts of Diverse Orientations Explore the Paradigm Prism, 2002. ,
Eye movement desensitization and reprocessing (EMDR): a meta-analysis, J Consult Clin Psychol. avr, vol.69, issue.2, pp.305-321, 2001. ,
Cognitive Behavioral Therapy versus Eye Movement Desensitization and Reprocessing in Patients with Posttraumatic Stress Disorder: Systematic Review and Meta-analysis of Randomized Clinical Trials, Cureus. 4 sept, vol.10, issue.9, p.3250, 2018. ,
Grounding Hypnosis in Science: The « New » APA Division 30 Definition of Hypnosis as a Step Backward, Am J Clin Hypn. avr, vol.57, issue.4, pp.390-401, 2015. ,
A history of hypnotism ,
Hypnosis and the treatment of posttraumatic conditions: an evidence-based approach, Int J Clin Exp Hypn. avr, vol.55, issue.2, pp.167-88, 2007. ,
,
, Harefuah. août, vol.152, issue.8, p.497, 2013.
Hypnotic approaches for chronic pain management: clinical implications of recent research findings, Am Psychol. mars, vol.69, issue.2, pp.167-77, 2014. ,
Soigner par l'hypnose. 5e édition, vol.352, 2012. ,
A Meta-Analysis for the Efficacy of Hypnotherapy in Alleviating PTSD Symptoms, Int J Clin Exp Hypn, vol.64, issue.1, pp.116-152, 2016. ,
, Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety, 2019.
, Psychotraumatismes : prise en charge et traitements -broché -Guillaume Vaiva, p.66
,
Treatment of posttraumatic stress disorder: the impact of paroxetine, Psychopharmacol Bull, vol.37, issue.1, pp.76-88, 2003. ,
Paroxetine in the treatment of post traumatic stress disorder: our experiences, Bosn J Basic Med Sci. févr, vol.8, issue.1, pp.76-85, 2008. ,
Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis, Br J Psychiatry. févr, vol.206, issue.2, pp.93-100, 2015. ,
Treatment of sleep disturbances in post-traumatic stress disorder, Mental Health Clinician. 1 mars, vol.4, issue.2, pp.91-98, 2014. ,
Treatment of sleep disturbances in posttraumatic stress disorder: a review, J Rehabil Res Dev, vol.49, issue.5, pp.729-52, 2012. ,
Prazosin Treatment of Nightmares Related to Posttraumatic Stress Disorder, Ann Pharmacother. 1 juin, vol.41, issue.6, pp.1013-1020, 2007. ,
Intérêt de la Prazosine comme traitement adjuvant dans les troubles du sommeil liés à un état de stress post traumatique, p.83 ,
Emerging roles for atypical antipsychotics in chronic posttraumatic stress disorder, Expert Rev Neurother. mars, vol.5, issue.2, pp.267-75, 2005. ,
A review of atypical antipsychotic medications for posttraumatic stress disorder, Int Clin Psychopharmacol. juill, vol.26, issue.4, pp.193-200, 2011. ,
Aripiprazole for Post-traumatic Stress Disorder: A Systematic Review, Clin Neuropharmacol. déc, vol.40, issue.6, pp.273-281, 2017. ,
The neurobiology of posttraumatic stress disorder: An integration of animal and human research, Posttraumatic stress disorder: A comprehensive text, pp.103-146, 1999. ,
Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder, Depression and Anxiety, vol.16, issue.1, pp.14-38, 2002. ,
Utility of P300 ERP in monitoring post-trauma mental health: A longitudinal study in military personnel returning from combat deployment, J Psychiatr Res, vol.101, pp.5-13, 2018. ,
Abnormal mismatch negativity in women with sexual assaultrelated posttraumatic stress disorder, Biol Psychiatry. 1 avr, vol.45, issue.7, pp.827-859, 1999. ,
Bilateral magnetic resonance imaging-determined hippocampal atrophy and verbal memory before and after temporal lobectomy, Epilepsia. juin, vol.37, issue.6, pp.526-559, 1996. ,
Atrophy of the hippocampus in posttraumatic stress disorder: how and when?, Hippocampus, vol.11, issue.2, pp.90-91, 2001. ,
Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder, Am J Psychiatry, vol.156, issue.11, pp.1787-95, 1999. ,
Brain activation in PTSD in response to trauma-related stimuli, Biol Psychiatry. 1 avr, vol.45, issue.7, pp.817-843, 1999. ,
Stress and the HPA Axis, Alcohol Res, vol.34, issue.4, pp.468-83, 2012. ,
The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder, Biol Psychiatry, vol.28, issue.8, pp.657-64, 1990. ,
The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress, Br J Psychiatry Suppl. févr, issue.15, pp.18-23, 1992. ,
Relationships between thyroid hormones and symptoms in combat-related posttraumatic stress disorder, Psychosom Med. août, vol.57, issue.4, pp.398-402, 1995. ,
Yohimbine use in a natural setting: effects on posttraumatic stress disorder, Biol Psychiatry. 1 août, vol.46, issue.3, pp.442-446, 1999. ,
Noradrenergic dysregulation in the pathophysiology of PTSD, Exp Neurol, vol.284, pp.181-95, 2016. ,
Biological studies of post-traumatic stress disorder, Nat Rev Neurosci, vol.13, issue.11, pp.769-87, 2012. ,
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission, Nat Rev Neurosci, vol.13, issue.1, pp.22-37, 2011. ,
On the relationship between emotion and cognition, Nat Rev Neurosci. févr, vol.9, issue.2, pp.148-58, 2008. ,
Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies, Neurosci Lett, vol.10, pp.147-55, 2017. ,
Serotonin and brain function: a tale of two receptors, J Psychopharmacol (Oxford), vol.31, issue.9, pp.1091-120, 2017. ,
Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder, Biol Psychiatry. 1 avr, vol.45, issue.7, pp.840-845, 1999. ,
D-fenfluramine challenge in posttraumatic stress disorder, Biol Psychiatry. 1 avr, vol.45, issue.7, pp.928-958, 1999. ,
,
, Nervenarzt. mars, vol.86, issue.3, pp.346-51, 2015.
Psychiatric comorbidity and co-occurring opioid misuse: Depression mediates the relationship between post-traumatic stress disorder and opioid misuse in community pharmacy settings, Subst Abus, pp.1-8, 2019. ,
Low plasma beta-endorphin in post-traumatic stress disorder, Aust N Z J Psychiatry. juin, vol.23, issue.2, pp.269-73, 1989. ,
Plasma beta-endorphin levels in post-traumatic stress disorder: a preliminary report on response to exercise-induced stress, J Neuropsychiatry Clin Neurosci, vol.4, issue.1, pp.59-63, 1992. ,
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST, Lancet. 16 mai, vol.1, issue.7342, pp.1080-1081, 1964. ,
, Résumé des caractéristiques du produit -PROPRANOLOL ACCORD 40 mg, comprimé pelliculé -Base de données publique des médicaments
,
Propranolol, post-traumatic stress disorder, and intensive care: incorporating new advances in psychiatry into the ICU, Crit Care. 19 déc, vol.18, issue.6, p.698, 2014. ,
Protein synthesis and consolidation of memory-related synaptic changes, Brain Res. 24 sept, vol.1621, pp.62-72, 2015. ,
Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala, Neuroscience, vol.129, issue.2, pp.267-72, 2004. ,
Between an ugly truth and a perfect lie: Wiping off fearful memories using beta-adrenergic receptors antagonists, J Cell Physiol. mai, vol.234, issue.5, pp.5722-5729, 2019. ,
Noradrenergic Modulation of Fear Conditioning and Extinction. Front Behav Neurosci, vol.13, 2018. ,
Propranolol produces short-term facilitation of extinction in a rabbit model of post-traumatic stress disorder, Neuropharmacology, vol.135, pp.386-98, 2018. ,
Propranolol's impact on cognitive performance in post-traumatic stress disorder, J Affect Disord. 1 mars, vol.192, pp.98-103, 2016. ,
Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder, J Psychiatr Res. mai, vol.42, issue.6, pp.503-509, 2008. ,
Trauma reactivation under the influence of propranolol decreases posttraumatic stress symptoms and disorder: 3 open-label trials, J Clin Psychopharmacol. août, vol.31, issue.4, pp.547-50, 2011. ,
Trauma reactivation plus propranolol is associated with durably low physiological responding during subsequent script-driven traumatic imagery, Can J Psychiatry. avr, vol.59, issue.4, pp.228-260, 2014. ,
Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial, Am J Psychiatry, vol.175, issue.5, pp.427-460, 2018. ,
The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents, Addiction. sept, vol.101, issue.9, pp.1241-1246, 2006. ,
Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. 1990 edition, vol.244, 1989. ,
History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS), J Psychoactive Drugs. mars, vol.46, issue.1, pp.27-36, 2014. ,
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, « ecstasy ») ,
, Pharmacol Rev. sept, vol.55, issue.3, pp.463-508, 2003.
Ecstasy: pharmacology and neurotoxicity, Curr Opin Pharmacol. févr, vol.5, issue.1, pp.79-86, 2005. ,
VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse, Ann N Y Acad Sci. janv, vol.1216, pp.86-98, 2011. ,
The Emerging Role of Trace Amine Associated Receptor 1 in the Functional Regulation of Monoamine Transporters and Dopaminergic Activity, J Neurochem. janv, vol.116, issue.2, pp.164-76, 2011. ,
The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder, J Psychoactive Drugs. déc, vol.47, issue.5, pp.337-381, 2015. ,
Decision-making in chronic ecstasy users: a systematic review, Eur J Neurosci, vol.45, issue.1, pp.34-44, 2017. ,
Safety pharmacology of acute MDMA administration in healthy subjects, J Psychopharmacol (Oxford), vol.31, issue.5, pp.576-88, 2017. ,
Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA). Psychopharmacology (Berl), vol.234, pp.2883-95, 2017. ,
, PTSD: From novel pathophysiology to innovative therapeutics, vol.10, pp.176-80, 2017.
A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder, p.69, 2015. ,
Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder, p.76, 2018. ,
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy, Front Psychiatry, vol.10, p.138, 2019. ,
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study, J Psychopharmacol (Oxford). avr, vol.25, issue.4, pp.439-52, 2011. ,
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamineassisted psychotherapy: a prospective long-term follow-up study, J Psychopharmacol (Oxford). janv, vol.27, issue.1, pp.28-39, 2013. ,
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial, J Psychopharmacol (Oxford), vol.32, issue.12, pp.1295-307, 2018. ,
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial, The Lancet Psychiatry. 1 mai, vol.5, 2018. ,
Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD, J Psychoactive Drugs. juin, vol.51, issue.2, pp.199-208, 2019. ,
A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD), J Psychopharmacol (Oxford). janv, vol.27, issue.1, pp.40-52, 2013. ,
Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis, Prog Neuropsychopharmacol Biol Psychiatry, vol.10, issue.2020, p.109735 ,